Scholar Rock Holding Stock Today
| SRRK Stock | USD 39.90 1.75 4.59% |
Performance9 of 100
| Odds Of DistressLess than 17
|
Scholar Rock is selling for 39.90 as of the 30th of November 2024. This is a 4.59% increase since the beginning of the trading day. The stock's last reported lowest price was 38.06. Scholar Rock has less than a 17 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Scholar Rock Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 24th of May 2018 | Category Healthcare | Classification Health Care |
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. The company has 93.61 M outstanding shares of which 15.14 M shares are at this time shorted by private and institutional investors with about 13.62 trading days to cover. More on Scholar Rock Holding
Moving together with Scholar Stock
| 0.83 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.82 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.77 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
Moving against Scholar Stock
Scholar Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | MPH MD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsScholar Rock can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Scholar Rock's financial leverage. It provides some insight into what part of Scholar Rock's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scholar Rock Holding (SRRK) is traded on NASDAQ Exchange in USA. It is located in 301 Binney Street, Cambridge, MA, United States, 02142 and employs 150 people. Scholar Rock is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.74 B. Scholar Rock Holding conducts business under Biotechnology sector and is part of Health Care industry. The entity has 93.61 M outstanding shares of which 15.14 M shares are at this time shorted by private and institutional investors with about 13.62 trading days to cover.
Scholar Rock Holding currently holds about 370.69 M in cash with (145.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.18.
Check Scholar Rock Probability Of Bankruptcy
Ownership AllocationScholar Rock Holding shows a total of 93.61 Million outstanding shares. The majority of Scholar Rock Holding outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Scholar Rock to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Scholar Rock Holding. Please pay attention to any change in the institutional holdings of Scholar Rock Holding as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Scholar Ownership Details
Scholar Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bellevue Group Ag | 2024-09-30 | 2.2 M | |
| Geode Capital Management, Llc | 2024-09-30 | 1.5 M | |
| Goldman Sachs Group Inc | 2024-06-30 | 1.3 M | |
| Orbimed Advisors, Llc | 2024-06-30 | 1.1 M | |
| Millennium Management Llc | 2024-06-30 | 925.6 K | |
| Clearbridge Advisors, Llc | 2024-09-30 | 924.4 K | |
| Citadel Advisors Llc | 2024-09-30 | 783.5 K | |
| Boxer Capital Llc | 2024-09-30 | 750 K | |
| Abrdn Plc | 2024-09-30 | 748.5 K | |
| Artal Group S A | 2024-06-30 | 11.3 M | |
| Fmr Inc | 2024-09-30 | 10.2 M |
Scholar Rock Historical Income Statement
Scholar Stock Against Markets
Scholar Rock Corporate Management
| Erin CPA | Senior Finance | Profile | |
| Junlin JD | General Secretary | Profile | |
| Erin Moore | Senior Finance | Profile | |
| Catherine Hu | IR Contact Officer | Profile | |
| Caryn Parlavecchio | Chief Officer | Profile | |
| Lisa Price | Senior Resources | Profile | |
| MBA MD | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scholar Rock Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scholar Rock. If investors know Scholar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scholar Rock listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.36) | Quarterly Revenue Growth (1.00) | Return On Assets (0.67) | Return On Equity (1.83) |
The market value of Scholar Rock Holding is measured differently than its book value, which is the value of Scholar that is recorded on the company's balance sheet. Investors also form their own opinion of Scholar Rock's value that differs from its market value or its book value, called intrinsic value, which is Scholar Rock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scholar Rock's market value can be influenced by many factors that don't directly affect Scholar Rock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scholar Rock's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scholar Rock is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scholar Rock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.